These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 17069803

  • 21. Summary: Registry data.
    Bates D.
    Neurology; 2011 Jan 04; 76(1 Suppl 1):S39-41. PubMed ID: 21205682
    [No Abstract] [Full Text] [Related]

  • 22. Effect of immunomodulation with human interferon-beta on early functional recovery from experimental spinal cord injury.
    Gok B, Okutan O, Beskonakli E, Palaoglu S, Erdamar H, Sargon MF.
    Spine (Phila Pa 1976); 2007 Apr 15; 32(8):873-80. PubMed ID: 17426631
    [Abstract] [Full Text] [Related]

  • 23. Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss.
    Brini E, Ruffini F, Bergami A, Brambilla E, Dati G, Greco B, Cirillo R, Proudfoot AE, Comi G, Furlan R, Zaratin P, Martino G.
    J Neuroimmunol; 2009 Apr 30; 209(1-2):33-9. PubMed ID: 19232440
    [Abstract] [Full Text] [Related]

  • 24. Is it time to consider rationalizing IFN-beta treatment in individuals with multiple sclerosis?
    Giovannoni G.
    J Neurol Neurosurg Psychiatry; 2004 Sep 30; 75(9):1234. PubMed ID: 15314107
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Neuroprotection without immunomodulation is not sufficient to reduce first relapse severity in experimental autoimmune encephalomyelitis.
    Hasseldam H, Johansen FF.
    Neuroimmunomodulation; 2010 Sep 30; 17(4):252-64. PubMed ID: 20203531
    [Abstract] [Full Text] [Related]

  • 28. Interferon-beta 1b: new hope for multiple sclerosis.
    Holdcroft C.
    Nurse Pract; 1994 Jan 30; 19(1):6. PubMed ID: 8139804
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A rare 'palisading' enhancing pattern of multiple sclerosis.
    Huang CF, Lo CP, Tseng CY, Chen YC.
    Eur Neurol; 2012 Jan 30; 67(3):161. PubMed ID: 22261728
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Brain Volume Loss During the First Year of Interferon-Beta Treatment in Multiple Sclerosis: Baseline Inflammation and Regional Brain Volume Dynamics.
    Vidal-Jordana A, Sastre-Garriga J, Pérez-Miralles F, Pareto D, Rio J, Auger C, Tintoré M, Rovira A, Montalban X.
    J Neuroimaging; 2016 Sep 30; 26(5):532-8. PubMed ID: 26935253
    [Abstract] [Full Text] [Related]

  • 33. Treatment of early onset multiple sclerosis with suboptimal dose of interferon beta-1a.
    Pakdaman H, Fallah A, Sahraian MA, Pakdaman R, Meysamie A.
    Neuropediatrics; 2006 Aug 30; 37(4):257-60. PubMed ID: 17177154
    [Abstract] [Full Text] [Related]

  • 34. Predictive markers for response to interferon therapy in patients with multiple sclerosis.
    Malucchi S, Gilli F, Caldano M, Marnetto F, Valentino P, Granieri L, Sala A, Capobianco M, Bertolotto A.
    Neurology; 2008 Mar 25; 70(13 Pt 2):1119-27. PubMed ID: 18272865
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Early immunotherapy in MS reduces the risk of later disability. The secondary progressive course is delayed, according to a study with virtual placebo].
    Tedeholm H, Skoog B, Hillert J, Runmarker B, Stawiarz L, Oluf A.
    Lakartidningen; 2008 Mar 25; 104(22):1684-8. PubMed ID: 17601317
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Should neutralizing antibodies be monitored during interferon-beta treatment for multiple sclerosis?
    Oger J, Gibbs E.
    Nat Clin Pract Neurol; 2006 Feb 25; 2(2):76-7. PubMed ID: 16932528
    [No Abstract] [Full Text] [Related]

  • 39. Interferon-beta: mechanism of action and dosing issues.
    Markowitz CE.
    Neurology; 2007 Jun 12; 68(24 Suppl 4):S8-11. PubMed ID: 17562848
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.